Catalyst Wire Dossier Catalyst Wire Dossier

Budesonide/Indacaterol

budesonide + indacaterol · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Budesonide/Indacaterol, covering 2017-04-18 to 2017-04-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD [Phase 4]

See pricing